Tuesday, October 15, 2019

ORF Panel Discussion - Bridging Access & Innovation in Healthcare Policy | 17th October


.


Greetings from the Observer Research Foundation!

ORF is pleased to invite you to a panel discussion on, "Bridging Access & Innovation in Healthcare Policy".  The event will take place on 17 October 2019, at Nilgiri room, The Oberoi, Dr.  Zakir Hussain Marg, New Delhi 110003.

About the panel discussion:

Expanding affordable access to innovative drugs will play a central role in addressing current and future global health challenges. This is particularly critical for low- and middle-income economies as they look to reduce disease burdens through innovative medicines and strengthen healthcare delivery. Is there a policy framework that would both incentivize life sciences companies to continue risk-taking investments into the research of transformative cures--and make these cures available to patients who can least afford but most need access to them? This discussion will seek to brainstorm & rebuild on best practice policies--including the convergence of intellectual property rights, voluntary licensing and strengthening healthcare infrastructure.

RSVP: architlohani29@gmail.com
 

Agenda:

10:30 - 11:00 hrs - Registration
11:00 - 11:10 hrs - Opening remarks
11:10 – 11:30 hrs- Keynote Address by Dr. Indu Bhushan, CEO, Ayushman Bharat*
11:30 – 12:30 hrs- Panel Discussion
Aaron Brinkworth, Executive Director, Access Operations & Emerging Markets, Gilead Sciences
Patrick Kilbride, Senior Vice President, Global Innovation Policy Center (GIPC)
Tanoubi Ngangom, Chief of Staff and Programmes, Observer Research Foundation (ORF)
Ashok Malik, Distinguished Fellow, Observer Research Foundation (ORF) (Moderator)
12:30 - 13:00 hrs - Moderated Q&A  
13:00 - 14:00 hrs – Lunch

 
 
We look forward to your participation
 
Regards,
Team ORF  
Copyright © 2019 Observer Research Foundation, All rights reserved.

Our mailing address is:
20, Rouse Avenue Institutional Area,
New Delhi-110002, India
Phone: +91 11 4352 0020
Website: orfonline.org


No comments: